Last reviewed · How we verify
NCT04041141
Oral Stent Device for Radiation Treatments of Oral Cancers
trial testing CT Scan in Tongue Tumor. Withdrawn.
3 February 2021
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 25 September 2019 |
| Primary completion | 3 February 2021 |
| Estimated completion | 3 February 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CT Scan — full drug profile →
- Experimental Oral Stent Device
Conditions studied
- Tongue Tumor — all drugs for Tongue Tumor →
- Tongue Cancer — all drugs for Tongue Cancer →
Sponsor
Indiana University
Who can join
18 and older, any sex, with Tongue Tumor or Tongue Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine that ability of the experimental oral stent device to reduce the volume of mandible receiving \>55 Gy by 50%during radiation treatment as assessed duri radiation treatment planning. Patients will have CT scans at three time-points during their standard of care radiation treatment. During these visits patients will receive scans via CT or cone beam CT scan, with both the standard and experimental oral stent devices. During radiation treatment patients will receive the standard oral stent device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04041141
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CT Scan
Trials testing the same drug.
- NCT06199479 — Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancie · Phase 1 · recruiting
- NCT04933617 — Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas · Phase 1 · terminated
- NCT04946552 — Sympathetic Activation in Obesity · NA · completed
- NCT04716907 — Thymic Function in Patients With COVID-19 · completed
- NCT04518722 — CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids · terminated
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04041141 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 9 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04041141.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing